Please login to create your UC TechAlerts.
Request a new password for
Required
Find technologies available for licensing from UC Davis.
No technologies match these criteria. Schedule UC TechAlerts to receive an email when technologies are published that match this search. Click on the Save Search link above
MicroRNA to Treat Traumatic Brain Injury
Researchers at the University of California, Davis has developed a microRNA-based treatment for traumatic brain injury.
A Combined Time-Walk and Timing-Shift Correction Method for Dual-Ended Readout TOF-DOI PET Detector
Researchers at the University of California, Davis have developed a technology that significantly improves the timing and spatial resolution of PET scans using dual-ended readout detectors.
Reversed Feedback Amplifier Architecture
Researchers at the University of California, Davis have developed a reversed feedback amplifier design for enhanced mm-wave signal amplification.
Synthetic, Non-Scheduled, Cannabinoid for Reducing the Frequency and Severity of Seizure
Researchers at the University of California, Davis have developed H2CBD, a fully synthetic analog of CBD designed to treat seizures without the psychoactive effects associated with Cannabis.
FIP (Feline Infectious Peritonitis) mRNA Vaccine
Researchers at the University of California, Davis have developed an approach to combat Feline Infectious Peritonitis (FIP) through an in vitro-transcribed (IVT) RNA vaccine targeting the FCoV nucleocapsid (N) protein antigen.
Monoclonal Antibodies Specific For Canine C-Kit
Please view this family of technologies HERE
Monoclonal Antibodies: CCR4 Antibody for Treating Canine Lymphoma and c-KIT Monoclonal Antibodies for Detecting and Treating Canine Mast Cell Tumors
Researchers at the University of California, Davis, have developed a monoclonal antibody for treating and diagnosing T cell lymphoma in dogs as well as monoclonal antibodies targeting c-KIT for treating and diagnosing mast cell tumors in dogs.
Monoclonal Neutralizing Antibodies Specific for Canine TNF Alpha
Researchers at the University of California, Davis have developed monoclonal antibodies engineered for the treatment and detection of autoimmune disorders and cancers in dogs.